Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer.

Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer.

Item
http://www.wikidata.org/entity/Q41116973
Prognostic value of inflammation-based scores in patients with osteosarcoma.Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer.Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle-invasive bladder cancer without carcinoma in situ.Peripheral inflammation/immune indicators of chemosensitivity and prognosis in breast cancer patients treated with neoadjuvant chemotherapy.Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer.Reduction of circulating lymphocyte count is a predictor of good tumor response after neoadjuvant treatment for rectal cancerBiomarkers for Predicting Clinical Outcomes of Chemoradiation-Based Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
P2860

Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer.

Item
http://www.wikidata.org/entity/Q41116973
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pre-treatment lymphocytopaenia ...... e and advanced bladder cancer.
@en
type
label
Pre-treatment lymphocytopaenia ...... e and advanced bladder cancer.
@en
prefLabel
Pre-treatment lymphocytopaenia ...... e and advanced bladder cancer.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Pre-treatment lymphocytopaenia ...... ve and advanced bladder cancer
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921